Meropenem/colistin versus meropenem/ampicillin–sulbactam in the treatment of carbapenem-resistant pneumonia H Khalili, L Shojaei, M Mohammadi, MT Beigmohammadi, A Abdollahi, ... Journal of comparative effectiveness research 7 (09), 901-911, 2018 | 32 | 2018 |
Clinical response and outcome of pneumonia due to multi-drug resistant Acinetobacter baumannii in critically ill patients L Shojaei, M Mohammadi, MT Beigmohammadi, M Doomanlou, ... Iranian journal of microbiology 8 (5), 288, 2016 | 20 | 2016 |
Potential nephroprotective effects of resveratrol in drug induced nephrotoxicity: a narrative review of safety and efficacy data F Shahbazi, F Farvadi, S Dashti-Khavidaki, S Ataei, L Shojaei Advances in Traditional Medicine 20, 529-544, 2020 | 8 | 2020 |
Clinical response and outcome in patients with multidrug resistant gram-negative infections M Malekolkottab, L Shojaei, H Khalili, M Doomanlou Journal of Research in Pharmacy Practice 6 (1), 44-51, 2017 | 7 | 2017 |
Remdesivir-associated significant bradycardia: a report of three cases M Shirvani, B Sayad, L Shojaei, A Amini, F Shahbazi The Journal of Tehran University Heart Center 16 (2), 79, 2021 | 5 | 2021 |
Potential drug-drug interactions in critically ill medical patients: a cross-sectional study E Hosseini, L Shojaei, H Karimpour, F Shahbazi Journal of Pharmaceutical Care, 52-57, 2018 | 4 | 2018 |
Analysis of QTc Interval during levofloxacin prescription in cardiac patients with pneumonia L Shojaei, M Ruzbahani, S Khajavian, S Shahsavari, N Tamasoki, ... Current Drug Safety 15 (2), 111-116, 2020 | 3 | 2020 |
Evaluation of Crocin Effect on Contrast-Induced Nephropathy Following Coronary Angiography or Angioplasty: A Randomized Controlled Trial L Shojaei, S Esfandiary, M Rouzbahani, F Heydarpour, M Bahremand, ... Iranian journal of pharmaceutical research: IJPR 21 (1), 2022 | 2 | 2022 |
Antimicrobial safety considerations in critically ill patients: part II: focused on anti-microbial toxicities F Shahbazi, L Shojaei, F Farvadi, S Kadivarian Expert Review of Clinical Pharmacology 15 (5), 563-573, 2022 | 2 | 2022 |
Antibiotic stewardship program in intensive care unit: first report from Iran G Vahidi, M Mohammadi, L Shojaei, M Ramezani, S Jafari, H Khalili International Journal of Critical Illness and Injury Science 8 (2), 83-89, 2018 | 2 | 2018 |
Probable drug eruption eosinophilia and systemic symptoms due to colistimethate sodium: A challenging case report H Karimpour, L Shojaei, F Shahbazi Infectious Diseases in Clinical Practice 28 (6), e58-e60, 2020 | 1 | 2020 |
Cationic albumin modified magnetite nanoparticles for localized delivery of sodium methotrexate E Cheraghipour, S Abolmaali, A Tamaddon, S Javadpour, L Shojaei Research in Pharmaceutical Sciences 7 (5), 190, 2012 | 1 | 2012 |
Efficacy and Safety of Rivaroxaban versus Warfarin in Patients with Coronary Endarterectomy: A Cross Sectional Study F Shahbazi, F Heydarpour, M Badrbani, M Azizi, A Kamari, M Bahremand, ... Journal of Pharmaceutical Care, 2024 | | 2024 |
Comparison of the Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients with or Susceptible to Thromboembolic Events F Shahbazi, F Heydarpour, A Kamari, M Azizi, M Bahremand, L Shojaei Iranian South Medical Journal 26 (1), 51-62, 2023 | | 2023 |
Hypertension medication from guidelines to practice: A cohort study in western Iran F Shahbazi, F Najafi, L Shojaei, MH Farzaei, Y Shokoohinia, Y Pasdar, ... Pharmacoepidemiology and drug safety 32 (9), 951-960, 2023 | | 2023 |
Determinants of Left Ventricular Systolic Function One Year after Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction in a Middle-Income Country RH Moghadam, N Salehi, S Mahmoudi, L Shojaei, S Nasiri, S Siabani, ... Archives of Iranian medicine 26 (2), 92, 2023 | | 2023 |
Antimicrobial safety considerations in critically ill patients: part I: focused on acute kidney injury F Shahbazi, L Shojaei, F Farvadi, S Kadivarian Expert Review of Clinical Pharmacology 15 (5), 551-561, 2022 | | 2022 |
Rapid and specific chromatography method on monolithic RP-column for determination of high-dose methotrexate pharmacokinetics in sera of cancer patients admitted to Shiraz Amir … L Shojaei, F Farvadi, S Zareifar, S Abolmaali, S Namazi, A Tamaddon Trends in Pharmaceutical Sciences 6 (3), 163-174, 2020 | | 2020 |
Hypertensive Crisis Associated with Serotonin Syndrome Following Linezolid Administration: Report of Two Cases F Shahbazi, L Shojaei Current drug safety, 0 | | |